Showing results (271-280 of 384) with videos related to

Sort By:
Pageof 39
Medical Oncology (Northwood, London, England)|August 22, 2018
Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcomaAlexandra Pender, Elizabeth J Davis, Dharmisha Chauhan, et al.
Acta Oncologica (Stockholm, Sweden)|June 11, 2025
Real-world data on immune checkpoint inhibitors in advanced sarcomas across multiple European institutionsStefania Kokkali, Ana Dolcan, Kjetil Boye, et al.
Cardiovascular Toxicology|July 3, 2009
Report and recommendations of the workshop of the European Centre for the Validation of Alternative Methods for Drug-Induced CardiotoxicityTina C Stummann, Mario Beilmann, Göran Duker, et al.
ESMO Open|August 28, 2020
Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre studyAnastasia Constantinidou, Nicolas Sauve, Silvia Stacchiotti, et al.
Future Oncology (London, England)|September 4, 2024
The INSIGHT study: a randomized, Phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with KIT exon 11 + 17/18 mutationsSuzanne George, Jean-Yves Blay, Ping Chi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 30, 2018
Desmoid fibromatosis through the patients' eyes: time to change the focus and organisation of care?Olga Husson, Eugenie Younger, Alison Dunlop, et al.
The Oncologist|September 12, 2020
A Timely Oral Option: Single-Agent Vinorelbine in Desmoid TumorsSpyridon Gennatas, Florence Chamberlain, Alannah Smrke, et al.
Clinical Sarcoma Research|May 12, 2020
Real-world experience with doxorubicin and olaratumab in soft tissue sarcomas in England and Northern IrelandSpyridon Gennatas, Florence Chamberlain, Thomas Carter, et al.
Bone & Joint Open|April 2, 2026
Optimal clinical management of tenosynovial giant cell tumours: a UK perspective, Sydney Stern, Robert Ashford, et al.
Cancer Medicine|May 7, 2021
Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancerRobin L Jones, Thomas J Herzog, Shreyaskumar R Patel, et al.
Pageof 39